ACQUIRED RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE BY PHENOTYPIC PLASTICITY OF MELANOMA

被引：0

作者：

Robitschek, Emily ^{[1
]}

Mehta, Arnav ^{[2
]}

Lin, Jia-Ren ^{[3
]}

Frederick, Dennie ^{[4
]}

Shi, Alvin ^{[5
]}

Larque, Ana ^{[6
]}

Miao, Benchun ^{[2
]}

Raghavan, Rumya ^{[7
]}

Sharova, Tatyana ^{[2
]}

Shin, John ^{[2
]}

Kellis, Manolis ^{[5
]}

Hacohen, Nir ^{[4
]}

Flaherty, Keith ^{[2
]}

Boland, Genevieve ^{[2
]}

Chebib, Ivan ^{[2
]}

Liu, David ^{[1
]}

Sullivan, Ryan ^{[2
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Massachusetts Gen Hosp, Boston, MA 02114 USA

[3] Harvard Med Sch, Boston, MA 02115 USA

[4] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA

[5] MIT, Boston, MA USA

[6] Hosp Clin Barcelona, Barcelona, Spain

[7] Broad Inst Harvard & MIT, Cambridge, MA USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.0916

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

916

引用

页码：A955 / A955

页数：1

共 50 条

[21] Targeting TNFR2 to overcome acquired adaptive resistance to immune checkpoint blockade
Mayer, Lena Sophie
Orlowski, Robert J.
Giles, Josephine
Benci, Joseph L.
Ellis, Gavin
Deng, Guoping
Attanasio, John
Chen, Zeyu
Bengsch, Bertram
Kahn, Omar
Manne, Sasikanth
Herati, Ramin S.
Ngiow, Shin
George, Sangeeth M.
Faustman, Denise L.
Gilliland, Gary
Mick, Rosemarie
Xu, Wei
McGettigan, Suzanne
Xu, Xiaowei
Amaravadi, Ravi K.
Karakousis, Giorgos C.
Schuchter, Lynn M.
Mitchell, Tara C.
Riley, James L.
Huang, Alexander C.
Minn, Andy
Tomov, Vesselin
Wherry, E. John
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[22] Immune and Molecular Correlates in Melanoma Treated With Immune Checkpoint Blockade
Byrne, Elizabeth H.
Fisher, David E.
CANCER, 2017, 123 : 2143 - 2153
[23] A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance
Huang, Alexander C.
Zappasodi, Roberta
NATURE IMMUNOLOGY, 2022, 23 (05) : 660 - 670
[24] A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance
Alexander C. Huang
Roberta Zappasodi
Nature Immunology, 2022, 23 : 660 - 670
[25] The role of interferons in melanoma resistance to immune checkpoint blockade: mechanisms of escape and therapeutic implications
Hargadon, K. M.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (06) : 1095 - 1104
[26] Predictors of responses to immune checkpoint blockade in advanced melanoma
Jacquelot, N.
Roberti, M. P.
Enot, D. P.
Rusakiewicz, S.
Ternes, N.
Jegou, S.
Woods, D. M.
Sodre, A. L.
Hansen, M.
Meirow, Y.
Sade-Feldman, M.
Burra, A.
Kwek, S. S.
Flament, C.
Messaoudene, M.
Duong, C. P. M.
Chen, L.
Kwon, B. S.
Anderson, A. C.
Kuchroo, V. K.
Weide, B.
Aubin, F.
Borg, C.
Dalle, S.
Beatrix, O.
Ayyoub, M.
Balme, B.
Tomasic, G.
Di Giacomo, A. M.
Maio, M.
Schadendorf, D.
Melero, I.
Dreno, B.
Khammari, A.
Dummer, R.
Levesque, M.
Koguchi, Y.
Fong, L.
Lotem, M.
Baniyash, M.
Schmidt, H.
Svane, I. M.
Kroemer, G.
Marabelle, A.
Michiels, S.
Cavalcanti, A.
Smyth, M. J.
Weber, S.
Eggermont, A. M.
Zitvogel, L.
NATURE COMMUNICATIONS, 2017, 8
[27] Melanoma: immune checkpoint blockade story gets better
Bhatia, Shailender
Thompson, John A.
LANCET, 2014, 384 (9948): : 1078 - 1079
[28] Immune Checkpoint Blockade in Patients With Melanoma Metastatic to the Brain
Di Giacomo, Anna Maria
Margolin, Kim
SEMINARS IN ONCOLOGY, 2015, 42 (03) : 459 - 465
[29] Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Bastian Schilling
Tim Schneider
Inga Möller
Antje Sucker
Annette Paschen
Dirk Schadendorf
Klaus G. Griewank
Journal of Translational Medicine, 13 (Suppl 1)
[30] Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
Sarver, Melissa
Brown, Michael C.
Rhodin, Kristen E.
Salama, April K. S.
Beasley, Georgia M.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)

← 1 2 3 4 5 →